Cargando…
Prospects of Novel and Repurposed Immunomodulatory Drugs against Acute Respiratory Distress Syndrome (ARDS) Associated with COVID-19 Disease
Acute respiratory distress syndrome (ARDS) is intricately linked with SARS-CoV-2-associated disease severity and mortality, especially in patients with co-morbidities. Lung tissue injury caused as a consequence of ARDS leads to fluid build-up in the alveolar sacs, which in turn affects oxygen supply...
Autores principales: | Nayak, Smruti Sudha, Naidu, Akshayata, Sudhakaran, Sajitha Lulu, Vino, Sundararajan, Selvaraj, Gurudeeban |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142859/ https://www.ncbi.nlm.nih.gov/pubmed/37109050 http://dx.doi.org/10.3390/jpm13040664 |
Ejemplares similares
-
Advances in computational frameworks in the fight against TB: The way forward
por: Naidu, Akshayata, et al.
Publicado: (2023) -
Structure-Based Virtual Screening Reveals Ibrutinib and Zanubrutinib as Potential Repurposed Drugs against COVID-19
por: Kaliamurthi, Satyavani, et al.
Publicado: (2021) -
Repurposing tetracyclines for acute respiratory distress syndrome (ARDS) and severe COVID-19: a critical discussion of recent publications
por: Garrido-Mesa, Jose, et al.
Publicado: (2022) -
Measles-induced respiratory distress, air-leak and ARDS
por: Piastra, M., et al.
Publicado: (2009) -
Kratom-Induced Acute Respiratory Distress Syndrome (ARDS)
por: Chinnappan, Justine, et al.
Publicado: (2023)